ArticleiScience2026
Temporal vision adaptation and restoration in achromatopsia.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Temporal vision is stronger under photopic conditions, as cones respond faster than rods, quantifiable via the temporal contrast sensitivity function (tCSF). We examined how the visual system adapts to congenitally slowed input in complete CNGA3/B3 achromatopsia (ACHM), a cone dysfunction forcing lifelong rod reliance, and whether gene therapy restoring cone function improves temporal resolution. Temporal vision was measured in 8 controls, 7 untreated ACHM, and 4 treated ACHM (3 adults and 1 child) under photopic and scotopic conditions, assessing tCSF maximal sensitivity, peak frequency, and flicker fusion frequency (FFF). Controls showed higher values under photopic than scotopic conditions. In untreated ACHM, photopic maximal sensitivity and FFF resembled controls' scotopic values, while peak frequency matched controls' photopic tuning. Among treated ACHM, only the child showed FFF approaching control levels. These findings suggest adaptive peak temporal tuning despite rod-limited resolution and indicate that treatment in childhood may restore temporal resolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.